NEW YORK, May 21 (Reuters) -
Cigna ( CI ) said on Wednesday it was launching an add-on to
pharmacy benefit management plans in which patients could pay no
more than $200 a month out-of-pocket for weight-loss drugs
Wegovy and Zepbound.
Cigna's ( CI ) pricing compares to the cash-pay market for
weight-loss drugs, said Harold Carter, a senior vice president
at Evernorth.